Actively Recruiting

All Genders
NCT06782984

Drug Response Testing and Repurposing Using Glioblastoma Organoid

Led by Chungnam National University Hospital · Updated on 2025-01-20

150

Participants Needed

1

Research Sites

484 weeks

Total Duration

On this page

Sponsors

C

Chungnam National University Hospital

Lead Sponsor

K

Korea Advanced Institute of Science and Technology

Collaborating Sponsor

AI-Summary

What this Trial Is About

The aim of this observational study, based on a prospectively collected cohort, is to evaluate the prognostic value of patient-derived organoids in predicting responses to conventional and repurposing drugs, including temozolomide, in patients with primary or recurrent glioblastoma. The primary question is whether the patient's response to temozolomide is recapitulated in their corresponding patient-derived glioblastoma organoid (GBO). Patient drug responses are evaluated using survival data, while GBO drug responses are assessed through a drug-response testing platform utilizing cell viability assays. Additionally, this platform is used to explore the potential application of various chemotherapeutic agents.

CONDITIONS

Official Title

Drug Response Testing and Repurposing Using Glioblastoma Organoid

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Primary or recurrent glioblastoma
  • Patients treated with standard treatment including surgery and temozolomide based chemoradiation therapy
  • Sufficient tumor sample is available for organoid culture
Not Eligible

You will not qualify if you...

  • Patients who have not undergone concurrent chemoradiation therapy following surgery
  • Failure to obtain MRI scan after concurrent chemoradiation therapy
  • Patient refusal

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Chungnam National University Hospital

Daejeon, Chungcheongnam-do, South Korea, 35015

Actively Recruiting

Loading map...

Research Team

K

Kyung Hwan Kim, MD, PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here